AI-assisted GNW on Adolescent Emotional Distress
Artificial Intelligence-Assisted Expressive Writing Intervention to Improve Adolescent Emotional Distress: A Cluster Randomized Controlled Trial
1 other identifier
interventional
900
1 country
1
Brief Summary
This cluster-randomized controlled trial aims to evaluate the efficacy of an AI-assisted Guided Narrative Writing (AI-GNW) in alleviating emotional distress among adolescents. Classes will be randomized in a 1:1:1 ratio to one of three arms-AI-GNW, a no-feedback GNW (NF-GNW), or a Neutral Writing Group (NWG)-and will complete a three-day writing intervention. On the first day, participants in both GNW conditions will recount a negative experience and reflect on their thoughts and feelings; on the second day, they will focus exclusively on the negative aspects of that experience; and on the third day, they will explore its positive dimensions. In contrast, NWG participants will objectively document their previous day's daily routine. After each session, those in the AI-GNW arm will receive individualized, AI-generated feedback, whereas NF-GNW participants will proceed without feedback.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2025
CompletedStudy Start
First participant enrolled
May 19, 2025
CompletedFirst Posted
Study publicly available on registry
August 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedAugust 5, 2025
July 1, 2025
6 months
May 16, 2025
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Revised Child Anxiety and Depression Scale (RCADS)
RCADS is a 25-item scale that includes 15 items for general anxiety and 10 for depression, rated on a 4-point Likert scale (0 = never, 3 = always). Higher scores mean more severe emotional distress
Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.
Insomnia Severity Index (ISI)
ISI is a 7-item, 5-point (0-4) Likert scale. Higher scores mean higher insomnia severity.
Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.
Secondary Outcomes (3)
Non-Suicidal Self-Injury Assessment Tool (NSSI-AT)
Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.
Suicidal Behaviors Questionnaire-Revised (SBQ-R)
Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.
Chinese PTSD Symptom Scale (CPSS)
Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.
Other Outcomes (6)
Adverse Childhood Experience Questionnaire (ACE)
Baseline (day 0)
Beijing Irritability Scale (BIS)
Baseline (day 0), post-intervention (day 4), and follow-ups at 1 (day 34),3 (day 64), and 6 (day 94) months after the intervention.
Positive Childhood Experience Questionnaire (PCE)
Baseline (day 0)
- +3 more other outcomes
Study Arms (3)
AI-GNW
EXPERIMENTALNF-GNW
ACTIVE COMPARATORNWG
SHAM COMPARATORInterventions
This is a three-day writing intervention. Each session lasts 20 minutes. On the first day, participants in both GNW conditions will recount a negative experience and reflect on their thoughts and feelings; on the second day, they will focus exclusively on the negative aspects of that experience; and on the third day, they will explore its positive dimensions. AI-GNW participants would receive AI-generated feedback.
In contrast, NWG participants will objectively document their previous day's daily routine.
Eligibility Criteria
You may qualify if:
- Native speakers of Chinese who are proficient in reading and writing Chinese.
- Signed a informed consent form and voluntarily agreed to participate.
- Owns a smartphone, tablet, or similar electronic device and is able to complete the required questionnaires and writing tasks.
You may not qualify if:
- Prior clinical diagnosis of schizophrenia or any other major psychiatric disorder.
- Presence of severe cognitive impairment, language-expression difficulties, or any other condition that would impede writing ability.
- Participation in another similar psychological intervention or psychotherapy within the past three months.
- Inability to tolerate a group-based intervention setting due to personal health conditions (e.g., serious illness).
- Unwillingness or inability to provide necessary cooperation or to sign the informed consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University
Haidian, Beijing Municipality, 100871, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- To maintain rigorous protection against bias, allocation to the AI-GNW, NF-GNW, or NWG arms was concealed from participants, interventionists, and those responsible for outcome evaluation. Participants were informed only that they would engage in a writing exercise and were unaware of the nature or content of the feedback provided in the AI-GNW arm. Investigators who facilitated the sessions did not have access to the randomization schedule or to any identifying information about group assignment. Outcomes assessors remained blind to each participant's study arm. This triple-masking procedure ensured that neither expectations nor assessment procedures could differentially influence intervention delivery or measurement of study endpoints.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 16, 2025
First Posted
August 5, 2025
Study Start
May 19, 2025
Primary Completion
November 1, 2025
Study Completion
November 1, 2025
Last Updated
August 5, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
To protect participants' privacy, authors wishing to access the data should contact the corresponding author and provide a statistical analysis plan addressing a new research question. The study trial management group will discuss all requests.